Toll-like receptor 3 in Epstein-Barr virus-associated nasopharyngeal carcinomas: consistent expression and cytotoxic effects of its synthetic ligand poly(A:U) combined to a Smac-mimetic
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toll-like receptor 3 in Epstein-Barr virus-associated nasopharyngeal carcinomas: consistent expression and cytotoxic effects of its synthetic ligand poly(A:U) combined to a Smac-mimetic
Authors
Keywords
-
Journal
Infectious Agents and Cancer
Volume 7, Issue 1, Pages 36
Publisher
Springer Nature
Online
2012-12-03
DOI
10.1186/1750-9378-7-36
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toll-Like Receptor 3 Ligand Polyinosinic:Polycytidylic Acid Promotes Wound Healing in Human and Murine Skin
- (2012) Qing Lin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
- (2011) Xuefeng Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer
- (2011) B. Salaun et al. CANCER RESEARCH
- Defective NF- B Signaling in Metastatic Head and Neck Cancer Cells Leads to Enhanced Apoptosis by Double-Stranded RNA
- (2011) N. Umemura et al. CANCER RESEARCH
- The dual role of TLR3 in metastatic cell line
- (2011) Tanja Matijevic et al. CLINICAL & EXPERIMENTAL METASTASIS
- cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms
- (2011) Maria Feoktistova et al. MOLECULAR CELL
- Role of EBER and BARF1 in nasopharyngeal carcinoma (NPC) tumorigenesis
- (2011) Kenzo Takada SEMINARS IN CANCER BIOLOGY
- Ripoptosome: a novel IAP-regulated cell death-signalling platform
- (2011) G. Imre et al. Journal of Molecular Cell Biology
- Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells
- (2010) Luc Friboulet et al. BMC CANCER
- Toll-Like Receptors: Cost or Benefit for Cancer?
- (2010) T. Matijevic et al. CURRENT PHARMACEUTICAL DESIGN
- TLR-signaling Networks
- (2010) J. Brown et al. JOURNAL OF DENTAL RESEARCH
- TLR3 and Rig-Like Receptor on Myeloid Dendritic Cells and Rig-Like Receptor on Human NK Cells Are Both Mandatory for Production of IFN- in Response to Double-Stranded RNA
- (2010) I. Perrot et al. JOURNAL OF IMMUNOLOGY
- Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells
- (2009) A Weber et al. CELL DEATH AND DIFFERENTIATION
- Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3
- (2009) Dai Iwakiri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events
- (2008) Karen A. Cavassani et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TLR signaling by tumor and immune cells: a double-edged sword
- (2008) B Huang et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search